Drugs / Adjuvanted Sub-unit Influenza Vaccine
Adjuvanted Sub-unit Influenza Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00644540 Comparator | Nov 2007 → Jan 2008 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adjuvanted Sub-unit Influenza Vaccine | “Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza...” NCT00644540 ↗ |
| Known as | FLUAD | “MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination” PMID 19840662 ↗ Oct 2009 |
| Known as | Sub/MF59 | “After priming with two intramuscular doses of MF59-adjuvanted (Sub/MF59) or split influenza vaccines during the 2006/07 season, 89 healthy children received a third booster...” PMID 19840662 ↗ Oct 2009 |
| Modality | Vaccine | “MF59-adjuvanted influenza vaccine” PMID 19840662 ↗ Oct 2009 |
| Route | Intramuscular | “administered intramuscularly (IM)” NCT00644540 ↗ |